Furthermore, amplifications of the BMP5 gene loci appeared to be more prevalent in tumors with a higher Gleason score and occurred in 50% of prostate tumors, which might account for the abnormal gene expression patterns of BMP5 in prostate cancer [27]. The gene discussed is BMP5; the disease is prostate carcinoma.